|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/551 | |
| A61K 9/20 |
| (11) | Patento numeris | 2854816 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13796870.7 |
| Europos patento paraiškos padavimo data | 2013-05-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-04-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-07-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/042959 |
| Data | 2013-05-29 |
| (87) | Numeris | WO 2013/181174 |
| Data | 2013-12-05 |
| (30) | Numeris | Data | Šalis |
| 201261653539 P | 2012-05-31 | US | |
| 201361787686 P | 2013-03-15 | US |
| (72) |
HARMON, Paul, A., US
VARIANKAVAL, Narayan, US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | SOLID DOSAGE FORMULATIONS OF AN OREXIN RECEPTOR ANTAGONIST |
| SOLID DOSAGE FORMULATIONS OF AN OREXIN RECEPTOR ANTAGONIST |